Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Unaudited Limited reviewed financial ....

OrchidPharm~W August 11, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai- 400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. 2015. as amended Sub: Prior Intimation of Board Meeting scheduled to be held on August 14. 2026 Dear Sir/Madam, With reference to captioned subject and in accordance with Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to intimate that the meeting of Board of Directors of Orchid Pharma Limited ("the Company") is scheduled to be held on Friday, August 14, 2026, inter alia, to consider and approve Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) of the Company for the Quarter-I of Financial Year 2026-27 ended on June 30, 2026. Restated Audited Standalone & Consolidated Financial Results of the Company for quarter and financial year ended on March 31, 2026 along with the restated statement of assets & liabilities, restated cash flow statement, revised auditors' reports on standalone and consolidated annual financial results issued by M/s. Singhi & Co., Statutory Auditors of the Company on account of Scheme of Amalgamation coming into effect. Further, in continuation to our earlier intimation dated June 26, 2026 stating the 'Trading Window Closure Period', we would like to inform that the Trading Window for dealing in the securities of the Company has been closed from July 01, 2026 ('Trading Window Closure commencement date') and shall continue to remain closed till the date on which 48 hours ends ('Trading Window Closure end date') after declaration of Unaudited limited reviewed Results (Standalone & Consolidated) of the Company for the Quarter-I of Financial Year 2026-27 ended on June 3D, 2026. You are requested to take the above intimation on record Thanking You, For Orchid Pharma Limited KapilOayya Company Secretary & compliance officer Mem No.: Fl0698 +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1, DLF Corporate Greens, Sector 74A, Plot Nos. 121-128, 128A-133, 138-151, 159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India.